TrialBlood2009

AAV-1-mediated gene transfer to skeletal muscle in humans results in dose-dependent activation of capsid-specific T cells.

Federico Mingozzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.